PLX3397 HCl(PLX3397 HCl) is a novel bioactive small molecule compound. Its chemical structure is (3Z,6Z,9Z,12Z)-N-(3-amino-1-ethyl-3-oxo-1, 3-Butanedio-2-propenyl)-3,12-bis (isopropyl-3-ethoxypropyl)-6,9-(isopropyl-3-ethoxypropyl)-2,5,8,11-four Aza fourteen skeleton dicarboxylic acid (C27H31N5O5).
PLX3397 HCl is an inhibitor of cytokine receptor tyrosine kinases and has anti-inflammatory and anti-tumor activity. It is mainly used in tumor-related research and treatment, especially in the treatment of malignant tumors such as gliomas, gastrointestinal tumors and leukemia.
The preparation of PLX3397 HCl is generally carried out by chemical synthesis. Specifically, it is usually synthesized by synthesizing and adjusting specific structural intermediates. It is necessary to pay attention to operating conditions and purity control during preparation to ensure safety and high-quality products.
Regarding safety information, PLX3397 HCl is a chemical drug, so use it in accordance with relevant regulations and operating guidelines. When used in laboratory and research environments, safety measures are required, including wearing gloves, goggles and protective clothing to avoid contact with skin and inhalation. In addition, the compound should be properly stored and handled on a case-by-case basis, and relevant waste disposal regulations should be followed to ensure environmental safety. The toxicity and safety guidelines should be understood in detail before use and should be used under the guidance of a professional.